Cancer Letters · 2020 · 39 citations · 38 references
MedicineCancer BiologyOncologyCancer GeneticsMolecular OncologyStem Cell BiologyCancer Stem Cell BiologyCancer Stem CellsMetabolic Reprogramming In CancerMicrorna BiologyMicrorna-mediated RegulationNoncoding Rna In CancerMalignant ProgressionMicrorna Function In CancerMicrorna Function In DifferentiationMicrorna In CancerMicrorna In Stem Cell RegulationMicrorna Regulation In CancerMirtron BiogenesisStemness Acquisition
Drosha-dependent canonical microRNAs (miRNAs) play a crucial role in the biological functions and development of cancer. However, the effects of Drosha-independent non-canonical miRNAs remain poorly understood. In our previous work, we found a set of aberrant miRNAs, including some upregulated miRNAs, called Drosha-independent noncanonical miRNAs, in Drosha-knockdown gastric cancer (GC) cells. Surprisingly, Drosha-silenced GC cells still retained strong malignant properties (e.g., proliferation ability and cancer stem cell (CSC) characteristics), indicating that aberrantly upregulated non-canonical miRNAs may play an important role in the maintenance of the malignant properties in GC cells that express low Drosha levels. Here, we report that miR-6778-5p, a noncanonical miRNA, acts as a crucial regulator for maintenance of CSC stemness in Drosha-silenced GC cells. MiR-6778-5p belongs to the 5'-tail mirtron type of non-canonical miRNAs and is transcript splice-derived from intron 5 of SHMT1 (coding cytoplasmic serine hydroxymethyltransferase). It positively regulates expression of its host gene, SHMT1, via targeting YWHAE in Drosha-knockdown GC cells. Similar to its family member SHMT2, SHMT1 plays a crucial role in folate-dependent serine/glycine inter-conversion in one-carbon metabolism. In Drosha wild type GC cells, SHMT2 mediates a mitochondrial-carbon metabolic pathway, which is a major pathway of one-carbon metabolism in normal cells and most cancer cells. However, in Drosha-silenced or Drosha low-expressing GC cells, miR-6778-5p positively regulates SHMT1, instead of SHMT2, thus mediating a compensatory activation of cytoplasmic carbon metabolism that plays an essential role in the maintenance of CSCs in gastric cancer (GCSCs). Drosha wild type GCSCs with SHMT2 are sensitive to 5-fluorouracil; however, Drosha low-expressing GCSCs with SHMT1 are 5-FU-resistant. The loss of miR-6778-5p or SHMT1 notably mitigates GCSC sphere formation and increases sensitivity to 5-fluorouracil in Drosha-knockdown gastric cancer cells. Thus, our study reveals a novel function of Drosha-independent noncanonical miRNAs in maintaining the stemness of GCSCs.
38
Claudia Allemani, Tomohiro Matsuda, V Di Carlo et al. · The Lancet · 2018 · 6.2K citations · Full text
Medicine, Biostatistics, Oncology +17
Intronic microRNA precursors that bypass Drosha processing
J. Graham Ruby, Calvin H. Jan, David P. Bartel · Nature · 2007 · 1.6K citations · Full text
Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
Shigeo Takaishi, Tomoyuki Okumura, Shuiping Tu et al. · Stem Cells · 2009 · 1K citations
Medicine, Cell Biology, Oncology +16
Eugène Berezikov, Wei‐Jen Chung, Jason Willis et al. · Molecular Cell · 2007 · 787 citations · Full text
Wen Cai Zhang, Ng Shyh‐Chang, Yang He et al. · Cell · 2012 · 673 citations · Full text